IPO || Gland Pharma || Company Overview || Lot size || Tentative Dates || GMP || Apply or Not?
About the company:-
Gland Pharma is Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest-growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets.
The company operates primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing, and marketing of complex injectables.
Gland Pharma now comes with an Approx. ₹6480 Crore IPO and it will be India’s largest pharma IPO in history.
The company’s key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. they are present in a vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more – to Hormones and Related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. The Company’s products are mainly used in the critical care segment and hence are highly quality-driven.
Gland Pharma IPO Dates, Price Band, Lot size:–
| Bid Open: | 09 November 2020 |
| Bid Close: | 11 November 2020 |
| IPO Size: | Approx. ₹6480 Crore |
| Price Band: | ₹1490 – ₹1500 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| QIB Portion: | 50% |
| NIB Portion: | 15% |
| Lot Size: | Minimum 10 Shares Maximum 130 Shares |
| Minimum Amount: | ₹15000/- |
| Maximum Amount: | ₹195000/- |
Gland Pharma IPO Allotment & Listing Tentative Date:-
| Finalization of Basis of Allotment: | 17 November 2020 |
| Initiation of Refunds: | 18 November 2020 |
| Credit to Demat Account: | 19 November 2020 |
| IPO Listing Date: | 20 November 2020 |
How to Apply for Gland Pharma IPO:-
Now you can apply for IPO through your De-MAT account. Just simply log in to your De-MAT Account and Go to the IPO section under the Investment option and select open IPOs and make payment through UPI Apps. and 2nd ways to apply is through the ASBA facility available in your Bank Account you have to just log in to your net banking and go to the Investment option and select Open IPO list, and if you have not Net banking then you can apply offline through Filling a simple form with your Brokers.
Note:- For Free Demat Account Opening or any Other Assistant you may Contact on +9187088-20004
Company Registered Address:–
Gland Pharma Limited
Sy. No. 143 – 148, 150 and 151,
Near Gandi Maisamma ‘X’ Roads, D.P. Pally, Dundigal
Medchal-Malkajgiri District, Hyderabad
Phone: +91 40 3051 0999
Email: investors@glandpharma.com
Website: http://www.glandpharma.com
Gland Pharma IPO book running lead managers:–
- Citigroup Global Markets India Private Limited
- Haitong Securities India Private Limited
- Kotak Mahindra Capital Company Limited
- Nomura Financial Advisory And Securities (India) Pvt Ltd
Gland Pharma IPO Grey Market Premium:-
50-60 as on today.
Note:- Grey Market Premium changing on daily basis do not subscribe just seeing GMP please consult before Investment with your Investment Planner or Adviser.
Our Review on Gland Pharma IPO:-
Should apply for listing gain and Long term Purpose.
!!!!!!Thank You !!!!!
